Search

everythinglearnresearchcommunity

for

Search:↓

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

People with male pattern baldness are more likely to have metabolic syndrome.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Kolaviron and quercetin may help treat prostate issues.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.